register

Marketing & Strategy

91% of clinicians use reprints to improve patient care

Health Industry Hub | November 18, 2019 |

For doctors, getting patient care right can be a case of life or death. They need to stay up to date with the latest research in their field, but that takes time – something that’s in short supply. It would seem logical, then, that doctors would welcome relevant and important medical studies in their inboxes, which they could use when diagnosing and treating patients.

With this in mind, pharmaceutical companies often sponsor and distribute reprints – republished versions of medical studies that doctors can use in their work, which are emailed to them for free.

Elsevier recently carried out an APAC based survey of physicians (download below) to find out whether doctors find these reprints useful, and to what extent reprints impact their work with patients. Carried out in December 2018 and January 2019, the survey asked physicians to share their experience using reprints.

The aim of the research was to understand how primary care physicians and specialists access and use scientific articles in reprint format, and why they choose certain content.

The responses provided insights across care areas: 343 physicians from APAC responded; about 80 percent were medical specialists and 20 percent were general practitioners.

Download the medical reprints infographic


Digital & Innovation

Meta finally admits to exploiting Aussie data for AI training: Call for privacy law reforms

Meta finally admits to exploiting Aussie data for AI training: Call for privacy law reforms

Health Industry Hub | September 13, 2024 |

Digital & Innovation: Facebook uses photos, posts and data from its adult Australian users to train AI models, Meta’s global […]

More


News & Trends - MedTech & Diagnostics

Policymakers undergo diabetes health check as push for equitable access to medical technologies escalates

Policymakers undergo diabetes health check as push for equitable access to medical technologies escalates

Health Industry Hub | September 13, 2024 |

MedTech News: Policymakers at Parliament House underwent a comprehensive health check yesterday, including assessments for HbA1c, cholesterol, blood pressure, and […]

More


News & Trends - Pharmaceuticals

Diabetes drugs underused in Australia despite proven benefits, study reveals

Diabetes drugs underused in Australia despite proven benefits, study reveals

Health Industry Hub | September 13, 2024 |

Pharma News: A new analysis has revealed that more Australians with type 2 diabetes should have access to potentially lifesaving […]

More


News & Trends - MedTech & Diagnostics

Landmark funding to expand genomic testing and precision medicine access for Victorian cancer patients

Landmark funding to expand genomic testing and precision medicine access for Victorian cancer patients

Health Industry Hub | September 13, 2024 |

Diagnostics News: A landmark funding contribution will establish an advanced genomic testing program in Victoria, aiming to deliver personalised, precision […]

More


This content is copyright protected. Please subscribe to gain access.